NCT01212887View on ClinicalTrials.gov

Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer

PHASE1TerminatedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
Breast CancerColorectal CancerGastric CancerLung CancerOvarian CancerPancreatic CancerUnspecified Adult Solid Tumor, Protocol Specific
Interventions
BIOLOGICAL

MFE23 scFv-expressing autologous anti-CEA MFEz T lymphocytes

BIOLOGICAL

aldesleukin

DRUG

cyclophosphamide

DRUG

fludarabine phosphate

OTHER

laboratory biomarker analysis

OTHER

pharmacological study

Trial Locations (1)

M20 4BX

Christie Hospital, Manchester

Sponsors

Lead Sponsor

Cancer Research UK
All Listed Sponsors
lead

Cancer Research UK

OTHER